对1型神经纤维素瘤患者预测建模的并发症的维度减少的评估
Aditi Gupta1, Ethan Hillis1, Inez Y Oh1
1Institute for Informatics, Data Science and Biostatistics, Washington University, Saint Louis, MO 63110, United States.
JAMIA open
|January 23, 2025
概括
缩小尺寸的技术改善了机器学习 (ML) 模型,用于使用电子健康记录 (EHR) 预测神经纤维素瘤类型1 (NF1) 亚现象型. 基于领域知识的方法优于不受监督的方法,突出了谨慎的特征聚合.
科学领域:
- 计算生物学和生物信息学
- 机器学习在医疗保健中的应用
- 基因组学和个性化医学
背景情况:
- 神经纤维素瘤类型1 (NF1) 是一种遗传性疾病,具有多样化的临床表现.
- 电子健康记录 (EHR) 包含丰富的数据,用于识别疾病的亚现象型.
- 降低维度对于处理高维的EHR数据和提高ML模型性能至关重要.
研究的目的:
- 为了比较各种维度减小技术对EHRs的并发症特征的有效性.
- 评估这些技术对预测NF1亚表型的ML模型性能的影响.
- 为儿科NF1研究确定最佳特征工程策略.
主要方法:
- 从儿科NF1患者的EHR中提取了并发症特征,使用国际疾病分类 (ICD) 代码,临床分类软件精制 (CCS) 和Phecode映射.
- 应用了10种不同的尺寸缩小方法来创建特征集.
- 在每个特征集上训练并比较了后勤回归,XGBoost和随机森林模型.
主要成果:
- XGBoost模型在预测NF1亚表型方面表现出最高的准确性.
- 来自域知识信息化映射方案的特征集优于无监督方法.
- 高级聚合特征导致表现最差,表明信息损失很大.
结论:
- 尺寸缩小显著影响了ML模型的性能,对算法和预测结果的变化有所不同.
- 使用知识和本体学数据库的自动化功能聚合可以有效处理EHR数据.
- 仔细优化缩小维度对于防止信息丢失和提高基于EHR的ML应用程序的预测准确性至关重要.
相关概念视频
01:14Multicompartment Models: Overview
90
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
90
01:21Cancer Survival Analysis
327
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
327
01:17Clearance Models: Noncompartmental Models
37
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
37